EOLS vs SRPT · rev $157.2M vs rev $1.13B
Evolus Inc (EOLS) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported EOLS revenue for 2026-06-30 was $157.2M. Net income was -$18.7M. EOLS currently screens at market cap $597.0M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
EOLS currently screens at market cap $597.0M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the EOLS and SRPT stock pages for the full models.
Not investment advice.